-+ 0.00%
-+ 0.00%
-+ 0.00%

Apogee Therapeutics CEO Michael Henderson disposes 20,000 common shares worth $1.64 million

PUBT·05/16/2026 00:00:48
Listen to the news
Apogee Therapeutics CEO Michael Henderson disposes 20,000 common shares worth $1.64 million
  • Apogee Therapeutics CEO Michael Thomas Henderson sold 20,000 shares on May 13, 2026.
  • Sales priced at USD 82.05 per share for 18,659 shares, USD 82.58 per share for 1,341 shares.
  • Henderson held 1,115,987 shares following transactions.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Apogee Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-062867), on May 15, 2026, and is solely responsible for the information contained therein.